Teva
Teva collaborates on skin disease treatment, releases targets
Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo
Teva seeks startups to help solve global pharmaceutical challenges
Placing the focus on the therapist
Does a common heart attack pill help everyone? Studies disagree
Irish medical consultants demand state not give sick children Israeli medicine
Teva Pharmaceuticals warned that such a move would “impose a risk on the health and wellbeing” of patients.
Teva’s ‘Support the Soul’ initiative strengthens Israel’s therapists post-October 7
Yarden Abarbanel notes how Teva's trauma-focused program empowers mental health providers nationwide
Former Teva CEO launched bid for World Zionist Congress, warns ‘Israel 4.0 is already here’
The World Zionist Congress, often called the “Jewish parliament,” is the official representative body of the global Jewish people in matters relating to Zionism.
Teva share price struggles to recover following $6 billion market loss
The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.
Teva falls sharply on disappointing 2025 guidance
"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products and key innovative products," said Teva CEO.
Corruption investigation opened into Teva following employee's complaint
The employee who submitted the complaint requested to be recognized as a whistleblower.
US analysts list Israeli giants Teva, Wix in 2025 top picks
In its survey of the Internet sector, Cantor Fitzgerald selected Wix, led by CEO Avishai Abrahami, as a top pick, along with Meta, Amazon, and DoorDash.
Who were the Israeli winners and losers of Wall Street in 2024?
Twelve Israeli companies rose more than 100% on Wall Street in 2024.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
EU set to fine Israeli company Teva for disparaging rival multiple sclerosis medicine, sources say
The long-running case against Teva started with EU dawn raids in 2019 that led to the opening of an investigation in 2021.
Teva joins world’s top 20 pharmaceutical companies
After years of financial and legal problems, Israel’s Teva Pharmaceutical Industries Ltd. named No.19 among the world’s top 20 best-earning pharmaceutical companies.
